Tempest Therapeutics, Inc. Restructuring Charges
Tempest Therapeutics, Inc. (TPST) reported Restructuring Charges of $53.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2018-11-09
- Tempest Therapeutics, Inc. restructuring charges for the quarter ending 2018-09-30 was $53.00K, a 85.32% decline year-over-year.
- Tempest Therapeutics, Inc. restructuring charges for the quarter ending 2018-06-30 was $2.89M, a 45.18% increase year-over-year.
- Tempest Therapeutics, Inc. restructuring charges for the quarter ending 2018-03-31 was $692.00K, a 53.49% decline year-over-year.
- Tempest Therapeutics, Inc. restructuring charges for the quarter ending 2017-12-31 was $188.00K, a 96.52% decline year-over-year.
- Tempest Therapeutics, Inc. restructuring charges for fiscal 2017 was $4.03M, a 25.37% decline from fiscal 2016.
- Tempest Therapeutics, Inc. restructuring charges for fiscal 2016 was $5.40M.
- Tempest Therapeutics, Inc. restructuring charges for fiscal 2015 was $0.00.
- Tempest Therapeutics, Inc. restructuring charges for fiscal 2014 was $0.00.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2018-09-30 | $53.00K 10-Q · filed 2018-11-09 | $2.94M derived: sum of 2 quarters · filed 2018-11-09 | $3.64M 10-Q · filed 2018-11-09 | $3.83M derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $2.89M 10-Q · filed 2018-08-09 | $3.58M 10-Q · filed 2018-08-09 | $3.77M derived: sum of 3 quarters · filed 2018-08-09 | $4.13M derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-03-31 | $692.00K 10-Q · filed 2018-05-03 | $880.00K derived: sum of 2 quarters · filed 2018-05-03 | $1.24M derived: sum of 3 quarters · filed 2018-11-09 | $3.23M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $549.00K derived: sum of 2 quarters · filed 2018-11-09 | $2.54M derived: sum of 3 quarters · filed 2018-11-09 | $4.03M 10-K · filed 2018-03-15 |
| 2017-09-30 | $361.00K 10-Q · filed 2018-11-09 | $2.35M derived: sum of 2 quarters · filed 2018-11-09 | $3.84M 10-Q · filed 2018-11-09 | $9.24M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $1.99M 10-Q · filed 2018-08-09 | $3.48M 10-Q · filed 2018-08-09 | $8.88M derived: sum of 3 quarters · filed 2018-08-09 | $8.88M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $1.49M 10-Q · filed 2018-05-03 | $6.89M derived: sum of 2 quarters · filed 2018-05-03 | $6.89M derived: sum of 3 quarters · filed 2018-05-03 | $6.89M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $5.40M derived: sum of 2 quarters · filed 2018-03-15 | $5.40M derived: sum of 3 quarters · filed 2018-03-15 | $5.40M 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-15 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |